Publications(1995)

・書籍
1)矢崎義雄、小川聡 編集、中谷晴昭(分担執筆)
膜電流と活動電位の成り立ちは
循環器NOW 8 不整脈　南江堂 1995 Jan; 53-5.

・和文雑誌
1)菅野盛夫、當瀬規嗣、中谷晴昭
クラスⅢ抗不整脈薬の作用機構と薬理学的意義
Japan Circ J 1995 Jan; 58(SupⅣ): 1232-7.

2)中谷晴昭、森勝巳、渡邊泰秀、原幸男、石川稔生
心筋リガンド感受性K+チャネルに対するアミオダロンの作用
日本薬理学雑誌 1995 Sep; 106(Sup1): 77-9.

3)中谷晴昭
抗不整脈薬：最近の動向
循環器専門医 1995 Oct; 3(2): 375-82.

4)中谷晴昭
不整脈治療薬1:不整脈の背景と発生のメカニズム
Medical World 1995; 11: 18-9.

・英文雑誌
1)Kohya T, Yokoshiki H, Tohse N, Kanno M, Nakaya H, Saito H, Kitabatake A.
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin Ⅱ blockade.
Circ Res 1995 May; 76(5): 892-9.

2)Mori K, Hara Y, Saito T, Masuda Y, Nakaya H.
Anticholinergic effects of class Ⅲ antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
Circulation 1995 Jun; 91(11): 2834-43.

3)Yamaguchi H, Uemura H, Saito T, Masuda Y, Nakaya H.
Vasopressin V1-receptor stimulation produces a positive inotropic response without affecting pHi in guinea pig papillary muscles.
Jpn J Pharmacol 1995 Jun; 68(2): 217-21.

4)Suzuki T, Okamoto Y, Sekikawa T, Nemoto T, Moriya H, Murayama S, Nakaya H.
Effects of GABAergic drugs on the recovery of reflex potentials after spinal cord ischemia in cats.
Jpn J Pharmacol 1995 Aug; 68(4): 423-9.

5)Suzuki T, Sekikawa T, Nemoto T, Moriya H, Nakaya H.
Effects of nicorandil on the recovery of reflex potentials after spinal cord ischaemia in cats.
Br J Pharmacol 1995 Sep; 116(2): 1815-20.

6)Takeda Y, Tohse N, Nakaya H, Kanno M.
Voltage-dependence of Ca2+ agonist effect of YC-170 on cardiac L-type Ca2+ channels.
Br J Pharmacol 1995 Oct; 116(3): 2134-40.

7)Hara Y, Nakaya H.
SD-3212, a new class Ⅰ and Ⅳ antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Br J Pharmacol 1995 Nov; 116(6): 2750-6.

8)Uemura H, Hara Y, Endou M, Mori K, Nakaya H.
Interaction of class Ⅲ antiarrhythmic drugs with muscarinic M2 and M3 receptors: radioligand binding and functional studies.
Naunyn Schmiedebergs Arch Pharmacol 1995 Dec; 353(1): 73-9.
  • 研究業績へ戻る